Potentiation of NMDA Receptors by AT1 Angiotensin Receptor Activation in Layer V Pyramidal Neurons of the Rat Prefrontal Cortex
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312644 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Adrienn Hanuska und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Biology, Semmelweis University, H-1089 Budapest, Hungary. Hauptthemen laut MEDLINE: Pyramidal Cells, Prefrontal Cortex, Receptors, N-Methyl-D-Aspartate, Receptor, Angiotensin, Type 1. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Innovation and Technology of Hungary from the National Research, Development, and Innovation Fund, National Research, Development, and Innovation Office of Hungary.
Abstract (Originalsprache)
NMDA receptors in the prefrontal cortex (PFC) play a crucial role in cognitive functions. Previous research has indicated that angiotensin II (Ang II) affects learning and memory. This study aimed to examine how Ang II impacts NMDA receptor activity in layer V pyramidal cells of the rat PFC. Whole-cell patch-clamp experiments were performed in pyramidal cells in brain slices of 9–12-day-old rats. NMDA (30 μM) induced inward currents. Ang II (0.001–1 µM) significantly enhanced NMDA currents in about 40% of pyramidal cells. This enhancement was reversed by the AT1 antagonist eprosartan (1 µM), but not by the AT2 receptor antagonist PD 123319 (5 μM). When pyramidal neurons were synaptically isolated, the increase in NMDA currents due to Ang II was eliminated. Additionally, the dopamine D1 receptor antagonist SCH 23390 (10 μM) reversed the Ang II-induced enhancement, whereas the D2 receptor antagonist sulpiride (20 μM) had no effect. The potentiation of NMDA currents in a subpopulation of layer V pyramidal neurons by Ang II, involving AT1 receptor activation and dopaminergic signaling, may serve as an underlying mechanism for the effects of the renin–angiotensin system (RAS) elements on neuronal functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Biology, Semmelweis University, H-1089 Budapest, Hungary.
- Department of Pharmacology and Pharmacotherapy, Semmelweis University, H-1089 Budapest, Hungary.
- Laboratory of Neuroendocrinology and In Situ Hybridization, Department of Anatomy, Histology and Embryology, Semmelweis University, H-1094 Budapest, Hungary.
- Laboratory of Molecular Pharmacology, HUN-REN Institute of Experimental Medicine, H-1083 Budapest, Hungary.
ORCID-Profile: Erzsébet Kató, Zoltán Giricz, Zsuzsanna E Tóth
Förderung
- Ministry of Innovation and Technology of Hungary from the National Research, Development, and Innovation Fund
- National Research, Development, and Innovation Office of Hungary
Zitieren
APA
Hanuska, A., Ribiczey, P., Kató, E., Papp, Z. T., Varga, Z. V., Giricz, Z., Tóth, Z. E., Könczöl, K., Zsembery, Á., Zelles, T., Harsing, L. G., & Köles, L. (2024). Potentiation of NMDA Receptors by AT1 Angiotensin Receptor Activation in Layer V Pyramidal Neurons of the Rat Prefrontal Cortex. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312644
Vancouver
Hanuska A, Ribiczey P, Kató E, Papp ZT, Varga ZV, Giricz Z, et al. Potentiation of NMDA Receptors by AT1 Angiotensin Receptor Activation in Layer V Pyramidal Neurons of the Rat Prefrontal Cortex. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312644
BibTeX
@article{Hanuska2024,
author = {Hanuska, Adrienn and Ribiczey, Polett and Kató, Erzsébet and Papp, Zsolt Tamás and Varga, Zoltán V and Giricz, Zoltán and Tóth, Zsuzsanna E and Könczöl, Katalin and Zsembery, Ákos and Zelles, Tibor and Harsing, Laszlo G and Köles, László},
title = {Potentiation of NMDA Receptors by AT1 Angiotensin Receptor Activation in Layer V Pyramidal Neurons of the Rat Prefrontal Cortex},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312644}
}
EUVIMED